0001493152-24-001131.txt : 20240104
0001493152-24-001131.hdr.sgml : 20240104
20240104194928
ACCESSION NUMBER: 0001493152-24-001131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231221
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Camaisa Allan
CENTRAL INDEX KEY: 0001990674
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40789
FILM NUMBER: 24514081
MAIL ADDRESS:
STREET 1: 4475 EXECUTIVE DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Calidi Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001855485
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 862967193
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4475 EXECUTIVE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-794-9600
MAIL ADDRESS:
STREET 1: 4475 EXECUTIVE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: First Light Acquisition Group, Inc.
DATE OF NAME CHANGE: 20210406
4
1
ownership.xml
X0508
4
2023-12-21
0
0001855485
Calidi Biotherapeutics, Inc.
CLDI
0001990674
Camaisa Allan
C/O CALIDI BIOTHERAPEUTICS, INC.
4475 EXECUTIVE DRIVE, SUITE 200
SAN DIEGO,
CA
92121
1
1
1
0
CEO, President and Chairman
0
Non-Qualified Stock Options (right to buy)
1.8
2023-12-21
4
A
0
100000
A
2023-12-21
2033-12-23
Common stock
100000
100000
D
Pursuant to the Issuer's 2023 Equity Incentive Plan (the "2023 Plan"), on December 21, 2023 (the "Grant Date"), the Reporting Person was granted 100,000 Non-Qualified Stock Options (the "Options") at an exercise price of $1.80, which is equal to the closing price of the Issuer's common stock on December 21, 2023 in consideration of Mr. Camaisa personally guaranteeing the raising of $12,500,000 of Series B preferred stock of Calidi Biotherapeutics, a Nevada corporation ("Old Calidi"), in connection with the Agreement and Plan of Merger, as amended ("Merger Agreement"), by and among First Light Acquisition Group, Inc., FLAG Merger Sub, Inc. ("Merger Sub"), First Light Acquisition Group, LLC, Allan Camaisa and Old Calidi. On September 12, 2023, Merger Sub merged with and into Old Calidi, with Old Calidi surviving the merger. The options were granted in a transaction exempt under Rule 16b-3.
/s/ Wendy Pizarro, Attorney-in-fact for Allan Camaisa
2024-01-04